Demographic and clinical characteristics of patients who underwent vertebral stent placement with distal protection for treatment of symptomatic vertebral artery origin stenosis
| Patient No./Age (y)/Sex | Stroke Severity | CVD Risk Factors | Lesion Length (mm) | Lesion Stenosis and Morphology | Stent | Lesion Stenosis (post) | Sheath Removal | ICU Days | Total Hospital Days | 1 m MRS |
|---|---|---|---|---|---|---|---|---|---|---|
| 1/71/M | Major | Hypertension, hyperlipidemia | 1.7 | 71%, regular | Bx VELOCITY Rx with Hepacoat 3.5 × 13 mm | 0% | Manual compress | 1 | 1 | 2 |
| 2/64/M | Major | Hypertension, NIDDM, cigarette smoking | 6 | 72%, regular | Multi-Link Zeta 3.5 × 13 mm | 5% | Manual compress | 1 | 14 | 3 |
| 3/78/F | Major | Hypertension, CAD | 4 | 66%, regular | CYPHER 3.5 × 8 mm | 8% | Manual compress | 1 | 1 | 3 |
| 4/81/M | Minor | Hypertension, NIDDM, CAD | 4 | 72%, regular | TAXUS 3.5 × 8 mm | 12% | Perclose | 1 | 1 | 2 |
| 5/67/F | Minor | Hypertension NIDDM, hyperlipidemia | 2.5 | 78%, regular | TAXUS 3.5 × 8 mm | 3% | Manual compress | 1 | 1 | 1 |
| 6/63/M | Major | Hypertenion, hyperlipidemia | 3 | 70%, regular | TAXUS 3.5 × 13 mm | 5% | Perclose | 1 | 28 | 4 |
| 7/52/M | Minor | Hypertension | 2 | 63%, regular | TAXUS 3.5 × 8 mm Multi-Link Zeta 3.5 × 13 mm | 2% | Perclose | 1 | 1 | 0 |
| 8/88/M | Minor | Hypertension, hyperlipidemia, past cigarette smoking | 4 | 67%, regular | TAXUS 3.5 × 12 mm | 2% | Manual compress | 1 | 1 | 2 |
| 9/68/M | Major | Hypertension, hyperlipidemia, cigarette smoking | 7 | 71%, irregular | CYPHER 3.5 × 23 mm | 7% | Manual compress | 1 | 1 | 1 |
| 10/71/F | Major | Hypertension, NIDDM, hyperlipidemia | 0.5 | 68%, regular | CYPHER 3.5 × 13 mm | 0% | Manual compress | 1 | 9 | 4 |
| 11/59/M | Major | Hypertension, NIDDM, cigarette smoking | 2.5 | 82%, regular | TAXUS 3.5 × 8 mm | 5% | Manual compress | 1 | 1 | 3 |
| 12/58/M | Major | Hyperlipidemia, cigarette smoking | 3 | 74%, regular | CYPHER 3.5 × 13 mm | 5% | Perclose | 1 | 10 | 4 |
Note:— CVD indicates cardiovascular disease; ICU, intensive care unit; MRS, Modified Rankin Scale; NIDDM, noninsulin-dependent diabetes mellitus; CAD, coronary artery disease.